Buy Erlonat/Erlotinib 150mg tablets with price | Myapplepharma

About This Presentation
Title:

Buy Erlonat/Erlotinib 150mg tablets with price | Myapplepharma

Description:

Erlonat/Erlotinib (Tarceva) 150mg Tablet is an anticancer medicine which is used in the treatment of pancreatic cancer, small cell lung cancer, various erlotinib side effects & price for erlonat mentioned etc @myapplepharma – PowerPoint PPT presentation

Number of Views:12

less

Transcript and Presenter's Notes

Title: Buy Erlonat/Erlotinib 150mg tablets with price | Myapplepharma


1
Erlonat 150mg tablet   Erlotinib 150mg tablets
  • Myapplepharma

2
Erlonat 150mg tablet (Erlotinib)
  • Erlonat tablets consist of active ingredients
    known as Erlotinib (Generic Tarceva), that is
    considered as quinazoline derivative and
    anti-cancer agents that responses as a protein
    kinase prohibitors for EGFR related to tyrosine
    kinase.
  •  Erlonat is majorly used in the treatment of
    non-small cell lung cancer and pancreatic
    carcinoma and also involved to treat various
    cancers. 
  • Erlonat 150mg is especially aimed the epidermal
    growth factor receptor tyrosine kinase.

3
USES OF Erlonat
  • Erlonat is indicated as continuance therapy, in
    patients with long lasting or metastasis non
    small cell lung carcinoma, whose disease has not
    get advance after four cycles with platinum based
    first line therapy
  • Erlonat is used in this condition only after the
    failure of one prior chemotherapy regimen. 
  • Erlonat 150mg with platinum based compounds like
    Carboplatin, gemcitabine or cisplatin. 

4
Erlonat WORKS
  • Erlonat has pharmacological effects like
    anti-neoplastic activity, which exhibits its
    action by inhibiting the intracellular
    phosphorylation of tyrosine kinase related with
    epidermal growth factor receptor.
  • This EGFR is present on the surface of the tumor
    cells.
  • Thus results as inhibition causes interfere with
    signal transduction and lead to cell lyses.

5
PHARMACOKINETICS
  • The peak plasma concentration time reaches at 4
    hours after drug intake After an oral
    administration of Erlonat, causes 60 of oral
    bioavailability. Increased by meals to 100.
  • Smoking should be avoided during the treatment
    with Erlonat 150mg, causes decreasing the
    exposure of Erlotinib. The apparent volume of
    distribution of Erlotinib is 232L Human protein
    binding to Erlotinib is occurs as 93. 
  •  Erlotinib metabolites occurs via Feces 83
    urine 8 half life period of Erlotinib is 36.2
    hours.

6
WARNING AND PRECAUTIONS
  • Pulmonary toxicity Interstitial lung disease and
    other pulmonary toxicity conditions, Avoid the
    treatment with Erlonat Renal failure Frequent
    monitoring of renal function or serum
    electrolytes occurs or avoids the treatment
  •  Hepatic function should be periodically
    monitored, or otherwise discontinue the therapy
    with Erlonat.

7
SOME INTERACTION WITH SOME OTHER DRUGS
  • Co administration of Erlonat with midazolam
    causes decreasing the AUC of CYP3A4 substrate.
    Drugs involved in alteration of pH levels causes
    variation in solubility of Erlotinib. Avoid
    concomitant use of gastric regulators
    with Erlonat.
  • Erlonat concomitant with statins drugs (lipid
    lowering drug), causes increasing the
    concentration of these drugs (rosuvastatin,
    simvastatin or atorvastatin).
  • CYP3A4 strong inhibitors like itraconazole, grape
    fruit juice, rotonavir, indinavir etc CYP3A4
    inducers concurrently used with Erlonat tablets
    causes decreasing the exposure of Erlotinib. 

8
CONTRAINDICATION
  • In Erlonat 150mg therapy, no contraindication
    occurs.
  • In some patients hypersensitivity reactions
    present due to patients are contraindicated to
    the ingredients in Erlonat.
  • In case of missed dose, patients must consult
    with medical oncologist and follow the regular
    dosing schedule.

9
SIDE EFFECTS
  • some undesirable effects like
  • Paronychia, Bullous, blistering and expoliative
    skin conditions like Stevens Johnsons syndrome.
    Gastrointestinal perforation Hepatic failure
    occurs during monotherapy or combination with
    other chemotherapy agents 
  • Some common side effects
  • Diarrhea, Fatigue, Anorexia, Pruritus, Acne,
    Dermatitis, Dry skin, Loss of weight, Paronychia,
    Cough, Vomiting, Conjunctivitis,
    Keratoconjuctivities sicca, Abdominal pain,
    Stomatits, Infection, nausea, Bone pain,
    Alopecia, Anxiety, Neuropathy, Renal disorders,
    hepatic disorders, ocular disorders, skin, hair
    and nail disorders.

10
Contact Us
  • phone No      9987711567
  • Email             info_at_myapplepharma.com
  • website         
  • https//myapplepharma.com/erlonat-150mg.php
Write a Comment
User Comments (0)